07/14/2025 / By S.D. Wells
A teenage girl in India has died after contracting the deadly Nipah virus, a bat-borne disease known to cause severe brain inflammation and carry a high mortality rate. Her death has raised serious concerns among public health experts about the virus’s pandemic potential, particularly as authorities are still investigating whether the disease has spread further through human contact.
The girl, who had reportedly developed symptoms of acute encephalitis syndrome (AES)—a condition marked by fever and rapid-onset neurological deterioration—succumbed to the infection just days after the U.S. formally ended its bird flu emergency response. Although another infected woman is currently being treated in a private hospital in Perinthalmanna, her condition and survival remain uncertain.
The Nipah virus, which is carried by fruit bats (Rousettus leschenaultii), is transmitted through bat saliva or droppings, especially in areas where humans and bats live in close proximity. Belonging to the same viral family as measles, Nipah is highly contagious and deadly, with the World Health Organization estimating a fatality rate between 40% and 70%. Health authorities have already tracked at least 425 people who may have been exposed, including 12 currently under treatment, with five in intensive care.
Nipah was first identified in 1999 in Malaysia and Singapore after an outbreak linked to pigs infected by fruit bats. Over 300 people became ill, and more than 100 died. Since then, the virus has triggered intermittent outbreaks in Bangladesh and India, particularly in Kerala, where proximity between humans and bats is more common. The 2018 outbreak in Kerala prompted international alarm and established the virus as a potential global health threat.
Adding to the unease, researchers have recently discovered two novel viruses closely related to both Nipah and Hendra—another deadly zoonotic virus. Meanwhile, a controversial new study published in Pathogens on June 18, 2025, has revealed that scientists funded by the U.S. National Institutes of Health (NIH) genetically engineered new hybrid viruses that combine elements from bat and human influenza strains.
This gain-of-function research, conducted at the University of Missouri with backing from the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), has sparked outrage and concern over biosecurity risks and pandemic preparedness.
Critics, including those writing for Natural News, question the timing of these developments, suggesting they may be more than coincidence. Some have speculated that these events could be part of a coordinated response—or even a deliberate strategy—to launch a new health crisis in the wake of waning public concern over bird flu.
While such claims remain speculative, the reemergence of Nipah and the discovery of engineered viral hybrids underscore the urgent need for transparent international health monitoring, robust containment protocols, and ethical oversight in biomedical research. As global surveillance continues, the world watches closely to see whether the Nipah virus remains contained—or becomes the next pandemic threat.
Bookmark Plague.info to your favorite independent websites for updates on TWO HUNDRED new gain-of-function viruses, including the new bat-human hybrid flu, that the globalists plan to release into the “wild” while blaming infected bat soup eaters at the Wuhan wet market.
Sources for this article include:
Tagged Under:
acute encephalitis syndrome, bat flu, biological warfare, biological weapons, bioterrorism, biowar, bioweapon, Brain, brain damaged, brain swelling, fruit bat flu, gain-of-function, hybrid flu, infections, NIH, Nipah virus, outbreak, pandemic, Plague, Plandemic
This article may contain statements that reflect the opinion of the author